AIZN Assurant, Inc. 5.25% Subordinated Notes due 2061
NYSE · Insurance · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026AIZN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
AIZN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Assurant, Inc. 5.25% Subordinated Notes due 2061 Hakkında Wikipedia'dan şirket genel bakışı
Assurant, Inc. is a global provider of risk management products and services with headquarters in Atlanta. Its businesses provide a diverse set of speciality, niche-market insurance products in the property, casualty, extended device protection, and insurance sectors. The company's main operating segments are Global Housing and Global Lifestyle.
The company, formerly known as Fortis, Inc., was spun off from Dutch and Belgian financial-services company Fortis Insurance N.V. in 2004. The company's initial public offering on Feb. 5, 2004 at $1.76 billion was the fourth largest that year. In connection with the public offering, the company changed its name to Assurant, Inc.
Assurant is 325 on the Fortune 500 list of the largest companies in the United States by revenue as of 2022.
History
Assurant can trace its roots back to the founding of the La Crosse Mutual Aid Association, which was established to sell disability insurance in Wisconsin in the early 1890s. La Crosse Mutual Aid Association would later become the Time Insurance Company.
In 1978, N.V. AMEV of the Netherlands acquired the Time Insurance Company via its U.S. holding company AMEV Holdings, Inc. During the next 12 years, AMEV Holdings, Inc. would expand through acquisition, buying American Security Insurance (credit-related insurance); United Family (funeral insurance); Western Insurance Company (mutual funds); and Superior Insurance (auto insurance).
In 1990, N.V. AMEV of the Netherlands acquired VSB Groep NV bank to become the Netherlands first financial conglomerate combining an insurer and a bank, creating Fortis.
In 1991, AMEV acquired the group life, accident and health insurance of Mutual Benefit Life Insurance Company. AMEV Holdings, Inc. was rebranded Fortis, Inc. in 1991. Superior Insurance was sold in 1996. Fortis acquired John Alden in 1998 and American Bankers Insurance in 1999.
Fortis Inc. sold its life insurance to The Hartford in 2001. Fortis' American business was subsequently renamed as Assurant and spun off from the parent company in 2004.
On June 10, 2015, Assurant announced an exit from the health insurance marketplace to focus on housing and lifestyle specialty protection products and services, and would be winding down its Assurant Health business. In October 2015, Assurant announced it had completed the sale of Assurant Health's existing supplemental and self-funded business lines to National General Holdings Corporation. Assurant began to wind down its major medical operations and did not participate in the next Affordable Care Act open enrollment period beginning in November 2015. Assurant sold its HSA assets and other medical-account assets to SelectAccount in March 2016. In 2015 Assurant also announced it was exiting the employee benefits marketplace. Sun Life Financial agreed to acquire Assurant Employee Benefits for $940 million in September 2015, and closed the sale in March 2016.
Operations
Assurant operates six main segments:
Global Housing, which offers lender-placed insurance, renters insurance, manufactured home insurance, residential and commercial flood insurance, rental deposit alternatives, insurance tracking, and loss draft services.
Telecommunications, which offers mobile device protection services, service and repair contracts for mobile phones, tech support services, lifecycle and sustainability solutions, and a global network of physical repair locations. This division also works with wholesale buyers of pre-owned devices to promote circularity through its global network of device care centers that process roughly 20 million devices annually as well as through relationships with subsidiaries such as (but not limited to) Hyla Mobile.
Retail and Consumer Goods, for which the company is the largest U.S. protection provider across electronics, appliances, and jewelry. This division also administrates Assurant Home Warranty, sold exclusively through real estate agents.
Global Automotive, which works with Auto Dealers, dealer groups, and third-party administrators in the U.S. and directly with auto brands and OEMs internationally. For these groups, Assurant provides a full suite of Finance & Insurance (F&I) products that include GAP insurance, extended warranties, extended and pre-paid service and maintenance contracts, vehicle protection plans, hybrid and electric vehicle (EV) protection and service plans, and access to a preferred auto repair network. This division also provides dealership development performance coaching, training through the Automotive Training Academy, and profit participation/reinsurance programs for dealers.
Commercial Vehicles & Equipment, which serves industries including medium, heavy-duty, and light-duty trucking; leased and financed equipment for businesses, medical offices, restaurants and more; and equipment for forestry, agriculture, and construction companies. Products in this sector include vehicle protection and service contracts, insurance tracking, point-of-funding protection solutions, and liability protection.
Financial Services, which primarily focuses on added-value protection products and travel benefits for credit card providers and the nearly 61 million consumers they serve. Assurant also provides expertise in actuarial services, policy and claims administration, and compliance/regulatory oversight.
Assurant Health policy claim denials and cancellations
Assurant Health (now divested from Assurant) was repeatedly found to cancel health policies for some customers that had serious medical conditions, and 12 states criticized the firm for denying claims, with most of the states levying fines against Assurant. A number of individual cases have been reported.
In September 2009, the South Carolina Supreme Court upheld a lower court's verdict that the firm (then known as "Fortis") wrongly revoked the health insurance policy of a holder who had contracted HIV subsequent to getting an insurance policy, and ordered the firm to pay $10 million to the plaintiff. The court found that:
Pursuant to company policy in cases involving long-term disease, Fortis launched an investigation to determine whether [the plaintiff] had failed to disclose a pre-existing condition on his policy application...A Fortis investigator reviewed the records and discovered [an] erroneously-dated intake note in [the doctor’s] files. That information was then forwarded to [a] Fortis Senior Underwriter...for review. [The underwriter]...recommended that [the plaintiff’s] policy be rescinded on the grounds that he had misrepresented his HIV positive status.
A Reuters report on the ruling stated that Fortis had a company policy to target every recently diagnosed HIV-positive policyholder for an automatic fraud investigation as a pretext to rescind their policy, according to undisclosed records. As in that case, their insurance policies often were canceled on incorrect information, flimsy evidence, or for no reason at all. In March 2010, the U.S. Supreme Court rejected the firm's appeal of the ruling.
In February 2010, a Boulder, Colorado jury found that Assurant Health had breached its contract with a woman who was severely injured in a hit-and-run accident, and awarded her $183,551 for medical bills and approximately $37.1 million in punitive damages. This was described as "one of the largest bad-faith judgments in Colorado history".
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | AIZN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 0.85Y ort. ≈1.9 | ≈1.9 | · | · | |
| F/S (TTM) | 0.15Y ort. ≈0.1 | ≈0.1 | · | · | |
| F/D (MRQ) | 0.15Y ort. ≈0.2 | ≈0.2 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 0.55Y ort. ≈1.6 | ≈1.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 0.55Y ort. ≈1.2 | ≈1.2 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 0.25Y ort. ≈0.7 | ≈0.7 | · | · | |
| PEG Ratio (PEG Oranı) | ≈0.0 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | AIZN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| EBITDA Margin (FAVÖK Marjı) | 1.9%5Y ort. ≈1.8% | ≈1.8% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | 9.9%5Y ort. ≈6.9% | ≈6.9% | · | · | |
| Net Kâr Marjı (TTM) | 7.9%5Y ort. ≈7.0% | ≈7.0% | · | · | |
| ROA (TTM) | 3.0%5Y ort. ≈2.2% | ≈2.2% | · | · | |
| ROE (TTM) | 18.3%5Y ort. ≈14.9% | ≈14.9% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | AIZN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 7.9%5Y ort. ≈6.0% | ≈6.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 7.9%5Y ort. ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 5.9% | · | · | · | |
| EPS YoY (EPS YB) | 17.1%5Y ort. ≈64.3% | ≈64.3% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 14.8%5Y ort. ≈58.9% | ≈58.9% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 49.7%5Y ort. ≈18.5% | ≈18.5% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 19.4% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 46.7%5Y ort. ≈14.1% | ≈14.1% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 14.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | AIZN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.45Y ort. ≈0.3 | ≈0.3 | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Eki 1, 2026 | $0,33 | USD | ≈7.6% |
| Tem 1, 2026 | $0,33 | USD | ≈7.0% |
| Nis 1, 2026 | $0,33 | USD | ≈6.7% |
| Ara 31, 2025 | $0,33 | USD | ≈6.7% |
| Eki 1, 2025 | $0,33 | USD | ≈6.5% |
| Tem 1, 2025 | $0,33 | USD | ≈6.3% |
| Nis 1, 2025 | $0,33 | USD | ≈6.8% |
| Ara 31, 2024 | $0,33 | USD | ≈6.5% |
| Eki 1, 2024 | $0,33 | USD | ≈5.9% |
| Tem 1, 2024 | $0,33 | USD | ≈6.4% |
| Mar 28, 2024 | $0,33 | USD | ≈5.8% |
| Ara 28, 2023 | $0,33 | USD | ≈6.6% |
| Eyl 28, 2023 | $0,33 | USD | ≈7.0% |
| Haz 29, 2023 | $0,33 | USD | ≈6.9% |
| Mar 30, 2023 | $0,33 | USD | ≈6.6% |
| Ara 29, 2022 | $0,33 | USD | ≈6.4% |
| Eyl 29, 2022 | $0,33 | USD | ≈6.2% |
| Haz 30, 2022 | $0,33 | USD | ≈5.9% |
| Mar 31, 2022 | $0,33 | USD | ≈5.7% |
| Ara 30, 2021 | $0,33 | USD | ≈5.7% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $6.41 | $5.23 | 22.5% | |
| 31 Mart 2026 | $5.95 | $5.35 | 11.3% | |
| 31 Aralık 2025 | $5.61 | $5.56 | 0.94% | |
| 30 Eylül 2025 | $5.73 | $4.32 | 32.7% | |
| 30 Haziran 2025 | $5.10 | $4.55 | 12.1% | |
| 31 Mart 2025 | $3.39 | $2.78 | 22.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B | $9.60B | $9.57B | $8.06B | $6.42B | $7.53B | $10.33B | $10.38B | |
| SG&A Expense | · | · | · | · | $3.25B | $3.05B | $3.19B | $2.98B | $2.71B | $3.44B | $3.92B | $3.69B | |
| Interest Expense | · | · | $108M | $108M | $112M | $104M | $111M | $100M | $50M | $58M | $55M | $58M | |
| Pretax Income | $1.09B | $927M | $807M | $350M | $771M | $578M | $455M | $334M | $444M | $849M | $201M | $744M | |
| Income Tax | $215M | $167M | $164M | $73M | $168M | $59M | $148M | $81M | $-75M | $283M | $60M | $273M | |
| Net Income | $873M | $760M | $642M | $277M | $1.36B | $441M | $383M | $251M | $520M | $565M | $142M | $471M | |
| EPS (Basic) | $17.14 | $14.55 | $12.02 | $5.09 | $22.95 | $7.02 | $5.87 | $4.00 | $9.45 | $9.23 | $2.08 | $6.52 | |
| EPS (Diluted) | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 | $6.98 | $5.84 | $3.98 | $9.39 | $9.13 | $2.05 | $6.44 | |
| Shares (Basic) | 50,469,633 | 51,703,588 | 52,870,380 | 54,371,531 | 59,140,861 | 60,114,670 | 61,942,969 | 59,239,608 | 54,986,654 | 61,261,288 | 68,163,825 | 72,181,447 | |
| Shares (Diluted) | 51,086,649 | 52,052,961 | 53,198,310 | 54,782,528 | 60,123,694 | 63,179,938 | 62,313,468 | 59,545,524 | 55,311,032 | 61,934,774 | 69,017,209 | 73,152,010 | |
| EBITDA | $250M | $224M | $196M | $182M | $172M | $144M | $126M | $127M | $116M | $125M | $137M | $132M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.83B | $1.81B | $1.63B | $1.54B | $2.04B | $2.21B | $1.87B | $1.25B | $997M | $1.03B | $1.29B | $1.32B | |
| Short-term Investments | · | · | · | · | · | · | $402M | $373M | · | · | · | · | |
| PP&E (Net) | $842M | $768M | $686M | $645M | $561M | $446M | $434M | $392M | $348M | $344M | $298M | $278M | |
| PP&E (Gross) | $1.49B | $1.27B | $1.08B | $1.05B | $917M | $780M | $762M | $766M | $696M | $678M | $756M | $792M | |
| Accum. Depreciation | $649M | $501M | $393M | $407M | $356M | $334M | $328M | $374M | $349M | $334M | $458M | $515M | |
| Goodwill | $2.65B | $2.62B | $2.61B | $2.60B | $2.57B | $2.59B | $2.21B | $2.32B | $918M | $831M | $834M | $841M | |
| Intangibles | $522M | $536M | $567M | $639M | $719M | $696M | $540M | $622M | $289M | $240M | $277M | $382M | |
| Total Assets | $36.29B | $35.02B | $33.64B | $33.12B | $33.92B | $44.65B | $44.29B | $41.09B | $31.84B | $29.71B | $30.04B | $31.56B | |
| Total Liabilities | $30.42B | $29.91B | $28.83B | $28.89B | $28.46B | $38.70B | $38.61B | $35.96B | $27.56B | $25.61B | $25.51B | $26.38B | |
| Long-term Debt | · | · | · | · | · | · | $2.01B | $2.01B | $1.07B | · | · | · | |
| Common Stock | $500.0K | $500.0K | $600.0K | $600.0K | $700.0K | $600.0K | $2M | $2M | $2M | $2M | $1M | $1M | |
| Retained Earnings | $4.83B | $4.38B | $4.03B | $3.70B | $4.04B | $3.55B | $5.97B | $5.76B | $5.70B | $5.30B | $4.86B | $4.81B | |
| Treasury Stock | $123M | $123M | $123M | $123M | $123M | $267M | $5.27B | $4.99B | $4.86B | $4.47B | $3.60B | $3.32B | |
| AOCI | $-544M | $-836M | $-765M | $-986M | $-150M | $710M | $412M | $-155M | $234M | $95M | $119M | $556M | |
| Stockholders' Equity | $5.87B | $5.11B | $4.81B | $4.23B | $5.46B | $5.95B | $5.65B | $5.11B | $4.27B | $4.10B | $4.52B | $5.18B | |
| Liabilities + Equity | $36.29B | $35.02B | $33.64B | $33.12B | $33.92B | $44.65B | $44.29B | $41.09B | $31.84B | $29.71B | $30.04B | $31.56B | |
| Shares Outstanding | 49,792,919 | 50,833,749 | 51,955,994 | 52,830,381 | 55,754,113 | 57,967,808 | 59,945,893 | 61,908,979 | 52,417,812 | 55,941,480 | 65,850,386 | 69,299,559 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $250M | $224M | $196M | $182M | $172M | $142M | $126M | $127M | $116M | $125M | $137M | $132M | |
| Stock-based Comp | $86M | $81M | $75M | $63M | $67M | $58M | $56M | $57M | $36M | $42M | $39M | $49M | |
| Deferred Tax | $101M | $245M | $-108M | $64M | $132M | $202M | $101M | $21M | $-4M | $25M | $-4M | $64M | |
| Amort. of Intangibles | $109M | $98M | $98M | $94M | $89M | $74M | $62M | $78M | $73M | $68M | $72M | $64M | |
| Restructuring | · | · | · | · | · | · | · | $2M | $3M | $31M | $86M | · | |
| Other Non-cash | $524M | $23M | $333M | $12M | $-961M | $506M | $760M | $200M | $-136M | $-623M | $-59M | $-323M | |
| Operating Cash Flow | $1.83B | $1.33B | $1.14B | $597M | $782M | $1.34B | $1.41B | $657M | $530M | $109M | $230M | $394M | |
| CapEx | $236M | $221M | $202M | $186M | $187M | $121M | $110M | $83M | $62M | $85M | $115M | $84M | |
| Investing Cash Flow | $-1.46B | $-658M | $-638M | $-262M | $158M | $-735M | $-620M | $-2.20B | $-541M | $726M | $264M | · | |
| Debt Issued | · | · | · | $0 | $347M | $244M | $347M | $1.29B | $0 | $250M | $0 | $0 | |
| Net Debt Issued | · | · | $-225M | $-76M | $-73M | $244M | $-33M | $1.29B | $0 | $250M | $0 | $0 | |
| Stock Repurchased | $304M | $307M | $193M | $573M | $839M | $297M | $272M | $139M | $389M | $863M | $293M | $215M | |
| Net Stock Activity | $-304M | $-307M | $-193M | $-573M | $-839M | $-297M | $-272M | $-139M | $-389M | $-863M | $-293M | $-215M | |
| Dividends Paid | $168M | $156M | $152M | $150M | $158M | $155M | $151M | $134M | $119M | $125M | $94M | $77M | |
| Financing Cash Flow | $-364M | $-478M | $-404M | $-818M | $-1.09B | $-265M | $-179M | $1.84B | $-27M | $-1.08B | $-462M | · | |
| Net Change in Cash | $26M | $180M | $91M | $-518M | $-174M | $362M | $613M | $257M | $-35M | $-256M | $-30M | $-399M | |
| Taxes Paid | $272M | $127M | $233M | $128M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.60B | $1.11B | $936M | $411M | $594M | $1.22B | $1.30B | $574M | $468M | $49M | $140M | $310M | |
| Levered FCF | · | · | $850M | $325M | $507M | $1.13B | $1.23B | $498M | $410M | $11M | $101M | $273M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 6.8% | 6.4% | 5.8% | 2.7% | 13.5% | 4.4% | 3.8% | 3.1% | 8.1% | 7.5% | 1.4% | 4.5% | |
| Pretax Margin | 8.5% | 7.8% | 7.2% | 3.4% | 7.7% | 5.1% | 5.5% | 4.1% | 6.9% | 11.3% | 1.9% | 7.2% | |
| EBITDA Margin | 1.9% | 1.9% | 1.8% | 1.8% | 1.7% | 1.4% | 1.2% | 1.6% | 1.8% | 1.7% | 1.3% | 1.3% | |
| ROA | 2.5% | 2.2% | 1.9% | 0.83% | 3.5% | 0.99% | 0.90% | 0.69% | 1.7% | 1.9% | 0.46% | 1.5% | |
| ROE | 15.3% | 14.7% | 13.8% | 6.6% | 24.0% | 7.6% | 7.1% | 5.3% | 12.4% | 13.1% | 2.9% | 9.4% |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $117.92 | $100.46 | $92.57 | $80.04 | $98.46 | $102.67 | $94.30 | $82.57 | $81.47 | $73.26 | $68.70 | $74.77 | |
| Revenue / Share | $250.83 | $225.89 | $206.97 | $186.06 | $169.44 | $159.78 | $161.87 | $135.32 | $115.98 | $121.61 | $149.61 | $141.92 | |
| Cash Flow / Share | $35.90 | $25.35 | $21.16 | $10.90 | $13.00 | $21.24 | $22.68 | $11.03 | $9.59 | $2.17 | $3.69 | $5.38 | |
| Cash / Share | $36.83 | $35.56 | $31.32 | $29.09 | $36.60 | $38.45 | $31.15 | $20.26 | $19.02 | $18.45 | $19.56 | $19.03 | |
| Dividend / Share | $3.28 | $2.96 | $2.82 | $2.74 | $2.66 | $2.55 | $2.43 | $2.28 | $2.15 | $2.03 | · | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $2.15 | $2.03 | $1.37 | $1.06 | |
| EPS (TTM) | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 | $6.98 | $5.84 | $3.98 | $9.39 | $9.13 | $2.05 | $6.44 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.9% | 6.7% | 9.2% | 0.05% | 6.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 5.2% | 5.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 17.1% | 21.0% | 136.6% | -77.7% | 224.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 49.7% | -13.9% | 19.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 14.8% | 18.3% | 132.3% | -79.7% | 208.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 46.7% | -17.7% | 13.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.7% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B | $9.60B | $9.57B | $8.06B | $6.42B | $7.53B | $10.33B | $10.38B | |
| Net Income TTM | $873M | $760M | $642M | $277M | $1.36B | $441M | $383M | $251M | $520M | $565M | $142M | $471M | |
| Market Cap | $968M | $1.02B | $1.04B | $1.07B | $1.50B | $1.59B | · | · | · | · | · | · | |
| P/E | 1.1 | 1.4 | 1.7 | 4.0 | 1.2 | 3.9 | · | · | · | · | · | · | |
| P/S | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| P/B | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | · | · | · | · | · | · | |
| P / Tangible Book | 0.4 | 0.5 | 0.6 | 1.1 | 0.7 | 0.6 | · | · | · | · | · | · | |
| P / Cash Flow | 0.5 | 0.8 | 0.9 | 1.8 | 1.9 | 1.2 | · | · | · | · | · | · | |
| P / FCF | 0.6 | 0.9 | 1.1 | 2.6 | 2.5 | 1.3 | · | · | · | · | · | · | |
| Dividend Yield | 17.4% | 15.3% | 14.7% | 14.1% | 10.5% | 9.8% | · | · | · | · | · | · | |
| Earnings Yield | 87.0% | 72.0% | 59.9% | 25.0% | 84.0% | 25.5% | · | · | · | · | · | · | |
| Payout Ratio | 19.3% | 20.5% | 23.7% | 54.3% | 11.5% | 35.0% | 39.6% | 53.3% | 22.9% | 22.2% | 66.5% | 16.5% | |
| Annual Payout | $168M | $156M | $152M | $150M | $158M | $155M | $151M | $134M | $119M | $125M | $94M | $77M |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.45B | $3.42B | $3.35B | $3.23B | $3.16B | $3.07B | $3.10B | $2.97B | $2.92B | $2.88B | $2.77B | $2.73B | $2.64B | $2.65B | $2.55B | $2.51B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $27M | · | $26M | $27M | |
| Pretax Income | $377M | $336M | $284M | $331M | $289M | $184M | $250M | $152M | $233M | $293M | $229M | $204M | $147M | $96M | $8M | $70M | |
| Income Tax | $78M | $62M | $58M | $66M | $54M | $37M | $49M | $18M | $44M | $56M | $39M | $48M | $34M | $28M | $1M | $18M | |
| Net Income | $299M | $274M | $225M | $266M | $235M | $147M | $201M | $134M | $189M | $236M | $190M | $156M | $114M | $68M | $7M | $52M | |
| EPS (Basic) | $5.98 | $5.47 | $4.46 | $5.22 | $4.60 | $2.86 | $3.90 | $2.56 | $3.59 | $4.50 | $3.55 | $2.91 | $2.12 | $1.32 | $0.14 | $0.96 | |
| EPS (Diluted) | $5.95 | $5.41 | $4.37 | $5.17 | $4.56 | $2.83 | $3.86 | $2.55 | $3.58 | $4.47 | $3.54 | $2.90 | $2.12 | $1.31 | $0.14 | $0.95 | |
| Shares (Basic) | 49,520,710 | 49,702,511 | · | 50,831,664 | 50,675,804 | 50,799,019 | · | 52,204,057 | 52,500,727 | 52,531,865 | 53,535,982 | 53,745,611 | 53,492,413 | · | 53,717,373 | 54,607,321 | |
| Shares (Diluted) | 49,831,416 | 50,197,547 | · | 51,320,491 | 51,112,351 | 51,248,716 | · | 52,464,522 | 52,717,736 | 52,872,254 | 53,745,173 | 53,889,682 | 53,698,162 | · | 54,066,605 | 55,014,947 | |
| EBITDA | · | $66M | · | · | · | $57M | · | · | · | $51M | · | · | $48M | · | · | · |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.70B | $1.59B | $1.83B | $1.71B | $1.49B | $1.67B | $1.81B | $1.81B | $1.71B | $1.28B | $1.43B | $1.40B | $1.53B | · | $1.43B | $1.18B | |
| PP&E (Net) | $850M | $849M | $842M | $831M | $812M | $786M | $768M | $742M | $733M | $706M | $664M | $643M | $671M | · | $618M | $609M | |
| PP&E (Gross) | · | · | $1.49B | · | · | · | $1.27B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $649M | · | · | · | $501M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $2.66B | $2.65B | $2.65B | $2.65B | $2.63B | $2.62B | $2.62B | $2.63B | $2.62B | $2.61B | $2.61B | $2.61B | $2.60B | $2.60B | $2.55B | $2.56B | |
| Intangibles | $488M | $511M | $522M | $528M | $530M | $552M | $536M | $546M | $555M | $563M | $590M | $608M | $616M | · | $631M | $676M | |
| Total Assets | $36.08B | $35.77B | $36.29B | $35.78B | $35.53B | $34.99B | $35.02B | $35.33B | $33.77B | $33.23B | $33.21B | $33.10B | $32.92B | · | $33.25B | $31.73B | |
| Total Liabilities | $29.98B | $29.90B | $30.42B | $30.02B | $30.03B | $29.75B | $29.91B | $30.08B | $28.77B | $28.31B | $28.72B | $28.62B | $28.52B | · | $29.15B | $27.27B | |
| Common Stock | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $600.0K | $600.0K | $600.0K | $600.0K | · | $600.0K | $600.0K | |
| Retained Earnings | $5.13B | $4.95B | $4.83B | $4.73B | $4.57B | $4.43B | $4.38B | $4.32B | $4.31B | $4.19B | $3.99B | $3.88B | $3.78B | · | $3.68B | $3.77B | |
| Treasury Stock | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | $123M | · | $123M | $123M | |
| AOCI | $-600M | $-629M | $-544M | $-547M | $-635M | $-748M | $-836M | $-627M | $-853M | $-811M | $-1.05B | $-923M | $-900M | · | $-1.08B | $-822M | |
| Stockholders' Equity | $6.10B | $5.87B | $5.87B | $5.76B | $5.50B | $5.23B | $5.11B | $5.26B | $5.00B | $4.92B | $4.49B | $4.49B | $4.40B | $4.23B | $4.10B | $4.46B | |
| Liabilities + Equity | $36.08B | $35.77B | $36.29B | $35.78B | $35.53B | $34.99B | $35.02B | $35.33B | $33.77B | $33.23B | $33.21B | $33.10B | $32.92B | · | $33.25B | $31.73B | |
| Shares Outstanding | 49,382,180 | 49,671,167 | 49,792,919 | 50,197,571 | 50,531,216 | 50,818,556 | 50,833,749 | 51,376,203 | 51,843,450 | 52,023,052 | 52,737,924 | 53,008,641 | 53,133,956 | 52,830,381 | 52,891,708 | 53,261,408 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $66M | $72M | $62M | $59M | $57M | $64M | $58M | $50M | $51M | $46M | $47M | $48M | $42M | $45M | $48M | |
| Stock-based Comp | $26M | $18M | $25M | $23M | $22M | $15M | $23M | $24M | $20M | $14M | $24M | $17M | $12M | $15M | $18M | $17M | |
| Other Non-cash | · | $-118M | · | · | · | $174M | · | · | · | $-219M | · | · | $85M | · | · | · | |
| Operating Cash Flow | $454M | $240M | $671M | $505M | $266M | $392M | $103M | $436M | $711M | $82M | $330M | $185M | $260M | $277M | $648M | $173M | |
| CapEx | $45M | $48M | $59M | $63M | $60M | $53M | $68M | $47M | $55M | $51M | $50M | $49M | $48M | $52M | $47M | $46M | |
| Investing Cash Flow | $-224M | $-282M | $-404M | $-270M | $-363M | $-422M | $71M | $-207M | $-193M | $-328M | $-157M | $-254M | $-229M | $-127M | $-242M | $120M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $173M | · | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $173M | · | · | · | |
| Stock Repurchased | $78M | $124M | $94M | $82M | $63M | $64M | $120M | $99M | $42M | $46M | $49M | $18M | $0 | $15M | $91M | $237M | |
| Net Stock Activity | · | $-124M | · | · | · | $-64M | · | · | · | $-46M | · | · | $0 | · | · | · | |
| Dividends Paid | $48M | $44M | $44M | $41M | $43M | $41M | $41M | $38M | $40M | $37M | $37M | $40M | $37M | $38M | $37M | $39M | |
| Financing Cash Flow | $-123M | $-203M | $-136M | $-5M | $-104M | $-119M | $-160M | $-141M | $-81M | $-96M | $-142M | $-57M | $-43M | $-51M | $-142M | $-347M | |
| Net Change in Cash | $107M | $-242M | $122M | $226M | $-183M | $-138M | $-6M | $100M | $431M | $-346M | $24M | $-124M | $-11M | $107M | $248M | $-77M | |
| Free Cash Flow | · | $193M | · | · | · | $339M | · | · | · | $32M | · | · | $211M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $10M | · | · | $190M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.6% | 8.0% | · | 8.2% | 7.4% | 4.8% | · | 4.5% | 6.5% | 8.2% | 6.9% | 5.7% | 4.3% | · | 0.29% | 2.1% | |
| Pretax Margin | 10.9% | 9.8% | · | 10.2% | 9.2% | 6.0% | · | 5.1% | 8.0% | 10.2% | 8.2% | 7.5% | 5.6% | · | 0.33% | 2.8% | |
| EBITDA Margin | · | 1.9% | · | · | · | 1.8% | · | · | · | 1.8% | · | · | 1.8% | · | · | · | |
| ROA | 0.83% | 0.77% | · | 0.75% | 0.68% | 0.43% | · | 0.39% | 0.56% | 0.71% | 0.57% | 0.48% | 0.34% | · | 0.02% | 0.13% | |
| ROE | 5.1% | 4.9% | · | 4.8% | 4.5% | 2.9% | · | 2.8% | 4.0% | 5.1% | 4.4% | 3.5% | 2.4% | · | 0.15% | 1.0% |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $123.48 | $118.17 | · | $114.72 | $108.81 | $103.00 | · | $102.29 | $96.53 | $94.57 | $85.15 | $84.63 | $82.74 | · | $77.50 | $83.73 | |
| Revenue / Share | $69.32 | $68.13 | · | $62.97 | $61.24 | $59.42 | · | $56.57 | $55.48 | $54.47 | $51.62 | $50.69 | $49.22 | · | $47.12 | $45.62 | |
| Cash Flow / Share | · | $4.79 | · | · | · | $7.59 | · | · | · | $1.56 | · | · | $4.83 | · | · | · | |
| Cash / Share | $34.40 | $32.04 | · | $34.12 | $29.42 | $32.85 | · | $35.30 | $33.04 | $24.64 | $27.03 | $26.44 | $28.71 | · | $27.03 | $22.19 | |
| Dividend / Share | $0.88 | $0.88 | $0.88 | $0.80 | $0.80 | $0.80 | $0.80 | $0.72 | $0.72 | $0.72 | $0.70 | $0.70 | $0.70 | $0.70 | $0.68 | $0.68 | |
| EPS (TTM) | $20.90 | $19.51 | · | $16.42 | $13.80 | $12.82 | · | $13.99 | $14.98 | $14.30 | $9.87 | $6.47 | $4.52 | · | $5.61 | $20.26 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.46B | $13.16B | · | $12.57B | $12.30B | $12.07B | · | $11.76B | $11.56B | $11.37B | $10.80B | $10.57B | $10.35B | · | $10.12B | $10.21B | |
| Net Income TTM | $1.06B | $1.00B | · | $849M | $717M | $670M | · | $741M | $798M | $765M | $528M | $345M | $241M | · | $322M | $1.19B | |
| Market Cap | $938M | $988M | · | $1.01B | $1.08B | $976M | · | $1.15B | $1.08B | $1.19B | $1.03B | $1000M | $1.04B | · | $1.13B | $1.19B | |
| P/E | 0.9 | 1.0 | · | 1.2 | 1.6 | 1.5 | · | 1.6 | 1.4 | 1.6 | 2.0 | 2.9 | 4.3 | · | 3.8 | 1.1 | |
| P/S | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| P/B | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | |
| P / Tangible Book | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | · | 1.2 | 1.0 | |
| P / Cash Flow | · | 4.1 | · | · | · | 2.5 | · | · | · | 14.4 | · | · | 4.0 | · | · | · | |
| Dividend Yield | 18.8% | 17.3% | · | 16.4% | 15.0% | 16.3% | · | 13.3% | 14.1% | 12.9% | 14.7% | 15.1% | 14.4% | · | 13.5% | 13.0% | |
| Earnings Yield | 110.0% | 98.0% | · | 81.8% | 64.3% | 66.7% | · | 62.3% | 71.6% | 62.7% | 50.6% | 34.3% | 23.2% | · | 26.4% | 91.1% | |
| Payout Ratio | · | 16.1% | · | · | · | 27.9% | · | · | · | 15.8% | · | · | 32.6% | · | · | · | |
| Annual Payout | $177M | $172M | · | $165M | $162M | $159M | · | $153M | $153M | $153M | $151M | $151M | $150M | · | $152M | $154M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $12.81B | $11.88B | $11.13B | $10.19B | $10.19B |
| Net Gelir | $873M | $760M | $642M | $277M | $1.36B |
| Seyreltilmiş Hisse Başı Kâr | $16.93 | $14.46 | $11.95 | $5.05 | $22.66 |
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $1.60B | $1.11B | $936M | $411M | $594M |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| TPG Advisors VI-AIV, Inc., David Bonderman, James G. Coulter | 25 Mart 2019 | · | İlk başvuru | Sermaye yapısı | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 19 içeriden öğrenenler · 9 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Keith Demmings | President and CEO | 16 Mart 2026 A | 136.635 | 0 | 2 | $-3.026.658 |
| Keith Meier | EVP, Chief Financial Officer | 15 Mayıs 2026 S | 18.552 | 0 | 1 | $-6.357.750 |
| Campbell Michael P. | EVP, COO | 16 Mart 2026 A | 27.443 | 0 | 0 | $0 |
| Robert Lonergan | EVP, CSTO | 22 Haziran 2026 S | 27.374 | 0 | 1 | $-1.838.970 |
| Dimitry Dirienzo | SVP, CAO, Controller | 26 Mayıs 2026 S | 2.741 | 0 | 2 | $-669.595 |
| Jay Rosenblum | EVP, Chief Legal Officer | 14 Mayıs 2026 S | 12.764 | 0 | 1 | $-503.540 |
| Subhashish Sengupta | EVP, Chief People Officer | 01 Nisan 2026 F | 2.746 | 0 | 2 | $-400.096 |
| Ryan Lumsden | EVP, Pres, Global Housing | 01 Nisan 2026 F | 17.298 | 0 | 0 | $0 |
| Jeffrey A. Strickland | EVP, Pres. Global Automotive | 16 Mart 2026 A | 5.996 | 0 | 0 | $0 |
| Rajiv Basu | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 3.731 | 0 | 0 | $0 |
| Lynn S. Blake | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 668 | 0 | 0 | $0 |
| Ognjen Redzic | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 8.136 | 0 | 0 | $0 |
| Sari Beth Granat | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 4.624 | 0 | 0 | $0 |
| Kevin M Warren | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 2.315 | 0 | 0 | $0 |
| Braxton J Carter II | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 8.961 | 0 | 0 | $0 |
| Elaine Rosen | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 27.686 | 0 | 0 | $0 |
| Harriet Edelman | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 11.114 | 0 | 0 | $0 |
| Paul J Reilly | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 22.155 | 0 | 0 | $0 |
| Biju Nair | · | 06 Ağustos 2026 S | 24.247 | 0 | 1 | $-1.188.970 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| FPE · First Trust Exchange-Traded Fund III | 0,24% | 781.216 NS | 31 Temmuz 2026 | N-PORT |
AIZN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AIZN | $968M | 1.1 | 7.9% | 6.8% | 15.3% | · |
| HIG | $38.16B | 10.3 | 6.9% | 13.5% | 21.4% | · |
| WRB | $26.45B | 15.8 | 7.8% | 12.1% | 19.7% | · |
| CINF | $25.38B | 10.8 | 11.4% | 18.9% | 16.0% | · |
| L | · | 13.2 | 5.4% | 9.0% | 9.3% | · |
| MKL | $27.06B | 12.7 | 4.7% | 13.6% | 11.9% | · |
| AIZ | · | · | · | · | · | · |
| CNA | $12.92B | 10.2 | 5.0% | 8.5% | 11.6% | · |
| AFG | $11.40B | 13.6 | -1.8% | 10.3% | 18.1% | · |
| FNF | $14.79B | 24.7 | 5.6% | 4.2% | 7.9% | · |
| ERIE | · | · | 7.2% | 13.8% | 25.0% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.